XML 95 R80.htm IDEA: XBRL DOCUMENT v3.22.4
Segment Reporting - Revenues and Operating Income by Reportable Segment (Details) - USD ($)
$ in Millions
 1 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Segment Reporting Information [Line Items]        
Revenues   $ 2,539.3 $ 2,225.1 $ 1,860.1
Adjusted EBITDA   380.2 339.6 256.6
Reconciliation of Adjusted EBITDA:        
Income (loss) before income taxes   110.3 81.2 (18.8)
Less: Net income attributable to non-controlling interests   (141.6) (141.6) (117.4)
Interest expense, net   234.9 221.0 201.8
Depreciation and amortization   114.8 98.8 94.8
Equity-based compensation expense   18.4 17.4 13.2
Transaction, integration and acquisition costs   48.6 46.1 38.2
Loss on disposals and deconsolidations, net   11.1 2.2 5.7
Litigation settlements and other litigation costs   (24.7) 5.6 6.4
Loss on debt extinguishment   14.9 9.1 0.0
Undesignated derivative activity   (8.0) 0.0 0.0
Hurricane-related impacts   1.5 (0.2) 0.0
Impairment charges   0.0 0.0 33.5
Gain on escrow release   0.0 0.0 (0.8)
Transaction and integration costs   47.5 39.8 23.2
Acquisition costs   1.1 6.3 15.0
Gain (loss) on litigation settlement $ 32.8 29.3 0.0 (1.2)
Other litigation costs   4.6 5.6 5.2
All other        
Segment Reporting Information [Line Items]        
Adjusted EBITDA   (91.1) (84.1) (80.7)
Surgical Facility Services | Operating Segments        
Segment Reporting Information [Line Items]        
Revenues   2,470.4 2,157.8 1,793.4
Adjusted EBITDA   473.6 422.0 339.3
Ancillary Services | Operating Segments        
Segment Reporting Information [Line Items]        
Revenues   68.9 67.3 63.6
Adjusted EBITDA   (2.3) 1.7 (3.4)
Optical Services | Operating Segments        
Segment Reporting Information [Line Items]        
Revenues   0.0 0.0 3.1
Adjusted EBITDA   $ 0.0 $ 0.0 $ 1.4